TGFB1 Protein and Benzyl-\documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{mathrsfs}\usepackage{upgreek}\setlength{\oddsidemargin}{-69pt}\begin{document}$$\alpha$$\end{document}α-GalNAc(O-galnac inhibitor) were then used to examine the impact of O-glycosylation on the TGFβ pathway in HCC. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.